BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23651953)

  • 1. Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl.
    von Schnurbein J; Heni M; Moss A; Nagel SA; Machann J; Muehleder H; Debatin KM; Farooqi S; Wabitsch M
    Horm Res Paediatr; 2013; 79(5):310-7. PubMed ID: 23651953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
    J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin replacement therapy for the treatment of non-HAART associated lipodystrophy syndromes: a meta-analysis into the effects of leptin on metabolic and hepatic endpoints.
    Rodríguez AJ; Neeman T; Giles AG; Mastronardi CA; Paz Filho G
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):783-97. PubMed ID: 25465598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation.
    Bolze F; Bast A; Mocek S; Morath V; Yuan D; Rink N; Schlapschy M; Zimmermann A; Heikenwalder M; Skerra A; Klingenspor M
    Diabetologia; 2016 Sep; 59(9):2005-12. PubMed ID: 27272237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of Rubi Fructus extracts on hepatic steatosis development in high-fat diet-induced obese mice.
    Nam MK; Choi HR; Cho JS; Cho SM; Ha KC; Kim TH; Ryu HY; Lee YI
    Mol Med Rep; 2014 Oct; 10(4):1821-7. PubMed ID: 25050832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin treatment: facts and expectations.
    Paz-Filho G; Mastronardi CA; Licinio J
    Metabolism; 2015 Jan; 64(1):146-56. PubMed ID: 25156686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease.
    Aller R; De Luis DA; Izaola O; González Sagrado M; Conde R; Pacheco D; Velasco MC; Ovalle HF
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):335-41. PubMed ID: 22530350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat and energy partitioning: longitudinal observations in leptin-treated adults homozygous for a Lep mutation.
    Heymsfield SB; Fong TM; Gantz I; Erondu N
    Obesity (Silver Spring); 2006 Feb; 14(2):258-65. PubMed ID: 16571851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy.
    Beltrand J; Beregszaszi M; Chevenne D; Sebag G; De Kerdanet M; Huet F; Polak M; Tubiana-Rufi N; Lacombe D; De Paoli AM; Levy-Marchal C
    Pediatrics; 2007 Aug; 120(2):e291-6. PubMed ID: 17671040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin-replacement therapy for lipodystrophy.
    Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
    N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating effects of casein glycomacropeptide on obesity induced by high-fat diet in male Sprague-Dawley rats.
    Xu SP; Mao XY; Cheng X; Chen B
    Food Chem Toxicol; 2013 Jun; 56():1-7. PubMed ID: 23416648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration.
    Chang ML; Yeh HC; Tsou YK; Wang CJ; Cheng HY; Sung CM; Ho YP; Chen TH; Yeh CT
    Obesity (Silver Spring); 2012 Jul; 20(7):1474-80. PubMed ID: 22421894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of leptin replacement on brain structure in genetically leptin-deficient adults.
    Matochik JA; London ED; Yildiz BO; Ozata M; Caglayan S; DePaoli AM; Wong ML; Licinio J
    J Clin Endocrinol Metab; 2005 May; 90(5):2851-4. PubMed ID: 15713712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.